Navigation Links
Boston University School of Medicine's Framingham Heart Study receives $1M challenge grant
Date:10/5/2009

(Boston) Boston University School of Medicine's (BUSM) Framingham Heart Study (FHS) has received a two-year $1M challenge grant from the National Heart, Lung, and Blood Institute.

According to FHS investigator Emelia Benjamin, MD, ScM, a professor of medicine at BUSM and professor of epidemiology at Boston University School of Public Health, the challenge grant will be used to add two statisticians to help identify risk factors for developing atrial fibrillation beyond the aging of the heart. FHS will also work with investigative groups at the University of Minnesota, with Joint-Principal Investigator, Alvaro Alonso, MD, PhD, as well as researchers in Iceland, Germany and the Netherlands.

The novelty of the FHS challenge study is that the investigative team includes collaborators at five other major cohort studies who will work together to develop the most accurate way to predict atrial fibrillation with simple clinical factors. The researchers will then examine whether new biomarkers or genetic tests add significantly to the ability to predict new-onset atrial fibrillation.

"It is a tremendous privilege to receive this challenge grant from the National Heart, Lung and Blood Institute," said Benjamin. "We now have the opportunity to make major headway in the prevention of atrial fibrillation."

The objective of the FHS is to identify the common factors or characteristics that contribute to cardiovascular disease by following its development over a long period of time in a large group of participants who have not yet developed overt symptoms of cardiovascular disease or suffered a heart attack or stroke.

The researchers recruited 5,209 people between the ages of 30-62 from the town of Framingham, Massachusetts. Since 1948, the participants have continued to return to the study every two years for a detailed medical history, physical examination and laboratory tests. In 1971, the study enrolled a second generation, 5,124 of the original participants' adult children and their spouses to participate in similar examinations. In April 2002, the study enrolled a third generation of participants, the grandchildren of the original cohort.

Over the years, careful monitoring of the FHS population has led to identification of major cardiovascular risk factors, as well as valuable information on the effects of these factors such as blood pressure, blood triglyceride and cholesterol levels, gender and psychological issues.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: